Browse the evidence

Exogenous antioxidant supplementation does not consistently extend lifespan in model organisms and may shorten it in healthy wild-type animals, contradicting the Free Radical Theory of Aging.

Do not rely on antioxidant supplements (Vitamins C, E, etc.) to extend your lifespan. Current evidence from model organisms suggests they are ineffective or potentially harmful in healthy individuals. Focus on established longevity interventions like calorie restriction or exercise, which have more robust evidence for extending healthspan and lifespan.

Resveratrol extends lifespan in some model organisms (yeast, nematodes, fish) primarily through indirect mechanisms like SIRT1 activation and calorie restriction mimicry, rather than direct antioxidant action.

Resveratrol may offer longevity benefits in specific contexts (e.g., metabolic dysfunction), likely by mimicking calorie restriction via SIRT1 activation. However, it is not a direct antioxidant and its benefits in healthy humans are unproven. Prioritize calorie restriction and exercise, which robustly activate these same pathways.

Activation of the GIP receptor, but not the GLP-1 receptor, increases plasma resistin levels.

This finding suggests that GIP receptor activation specifically influences resistin levels, a marker associated with insulin resistance. This adds nuance to the understanding of how different incretin pathways affect metabolic health markers beyond glucose and weight.

Higher plasma concentrations of odd-chain fatty acids (specifically pentadecanoic and heptadecanoic acid) are significantly inversely associated with the risk of incident coronary heart disease.

Odd-chain fatty acids, which are biomarkers for dairy intake, are associated with a lower risk of heart disease. This suggests that not all saturated fats are harmful and that moderate dairy consumption may be part of a heart-healthy diet.

Insulin is the primary regulator of human adipose tissue lipoprotein lipase (LPL) activity; insulin deficiency (as in untreated diabetes) significantly reduces LPL activity, while elevated insulin levels (as in obesity or post-prandial states) increase it.

Your body's ability to store fat in adipose tissue is directly controlled by insulin. When you are insulin-deficient (untreated diabetes), fat storage capacity (LPL) is low. When you have high insulin (obesity or after eating carbs), fat storage capacity increases. Managing insulin secretion through dietary carbohydrate intake is the lever to control this enzyme's activity.

Metformin lowers blood glucose in Type 2 Diabetes primarily through gut-based pharmacology (altering bile acid recirculation and gut microbiota to enhance GLP-1 secretion) rather than solely through AMPK activation in the liver and muscle.

Metformin's effectiveness in Type 2 Diabetes relies heavily on its interaction with your gut, not just your liver. It changes your bile acids and gut bacteria, which triggers the release of GLP-1, a hormone that helps control blood sugar. This is why taking it orally is crucial; injecting it bypasses this gut mechanism and is less effective.

High oxidative muscle fibers remain small despite high protein synthesis capacity because increased mitochondrial biogenesis via AMPK attenuates myofibrillar protein synthesis and higher expression of E3-ligases increases protein degradation.

High oxidative (Type I) fibers are genetically predisposed to be smaller and more fatigue-resistant. They have higher rates of protein turnover (both synthesis and degradation). To maximize size in these fibers, resistance training must overcome the natural tendency for degradation and the inhibitory effects of mitochondrial signaling.

The maximum rate of oxygen consumption (VO2max) per unit volume is inversely proportional to muscle fiber cross-sectional area (CSA) due to oxygen diffusion constraints, creating an evolutionary design constraint where larger fibers cannot support high oxidative capacity without developing anoxic cores.

As muscles get larger, their ability to use oxygen efficiently per unit of volume decreases. This is why bodybuilders often have lower VO2max relative to their muscle mass compared to endurance athletes. You cannot simply 'train' away this physical diffusion limit, though capillary density can help mitigate it.

Methionine restriction (MetR) extends lifespan across multiple species, including yeast, worms, flies, and mammals, by modulating methionine metabolism pathways and methyltransferase activity.

Restricting dietary methionine has been shown to extend lifespan in various model organisms. This involves reducing intake of methionine-rich foods. The exact mechanism involves modulating methionine metabolism and methyltransferase activity, potentially through reducing translation rates, modifying gene expression, or inducing hormetic responses.

Regulation of methyltransferases and the SAM/SAH ratio plays a crucial role in lifespan extension by methionine restriction.

Maintaining a healthy balance of SAM and SAH levels may be important for longevity. This can be influenced by dietary methionine intake and genetic factors affecting methionine metabolism.

Higher intake of alcohol (per 10 g/day increment) is associated with an 8% higher risk of colorectal cancer, independent of meat and fiber intake.

Increasing alcohol intake is linked to a higher risk of colorectal cancer. For every 10 grams of alcohol consumed per day, risk increases by 8%. Reducing alcohol intake can help lower this risk.

Fish, poultry, cheese, tea, and coffee consumption are not associated with colorectal cancer risk in this study.

You do not need to avoid fish, poultry, cheese, tea, or coffee due to colorectal cancer risk, as this study found no association.

Remote patient monitoring (RPM) using wearable biosensors alone does not significantly improve clinical outcomes such as BMI, weight, blood pressure, or body fat percentage compared to usual care.

Do not rely on wearable devices alone to manage chronic conditions like obesity or hypertension. The evidence shows that simply wearing a tracker does not significantly change clinical outcomes like weight or blood pressure. To see benefits, RPM must be combined with active interventions like personalized coaching, behavioral therapy, or clinician feedback loops.

Genetic variants associated with obesity (such as FTO) explain less than 3% of BMI variation, failing to account for the 47-80% heritability estimates or the rapid global rise in obesity prevalence.

Do not blame your genetics for obesity. Current science shows that known genetic markers account for less than 3% of body weight variation. The rapid global increase in obesity is driven by environmental and lifestyle factors, not a sudden change in human DNA. This means your daily choices regarding diet and activity have a disproportionately large impact on your weight compared to your genetic predisposition.

Socioeconomic status (SES) is a strong determinant of childhood obesity, with low SES in developed countries associated with a 41% higher risk of obesity in children aged 0-15.

In developed countries, lower socioeconomic status is a major risk factor for childhood obesity, increasing the risk by 41%. This is largely due to structural factors like limited access to healthy food and safe places for physical activity, rather than just individual choices. Interventions should focus on improving access and environment.

Caloric restriction (30-40%) delays age-related DNA methylation drift, resulting in a significantly younger biological (methylation) age compared to chronological age in mice and rhesus monkeys.

In animal models, sustained caloric restriction (30-40% reduction) significantly slows the epigenetic aging clock, making biological tissues appear years younger than their chronological age. This suggests that managing energy intake may be a potent lever for delaying molecular aging processes in mammals.

Deficiency of Estrogen Receptor Beta (ERβ) in adipose tissue leads to increased body fat mass but improved systemic insulin sensitivity and glucose tolerance under high-fat diet conditions, mediated by enhanced PPARγ signaling.

This research suggests that the presence or absence of specific estrogen receptors (ERβ) in fat tissue dictates whether fat accumulation harms or helps metabolic health. While this is a genetic/mechanistic finding in mice and not a direct human intervention, it implies that simply reducing fat mass is not the only path to metabolic health; the hormonal environment of the fat tissue is critical.

High intra-abdominal fat (IAF) is the primary determinant of an atherogenic lipoprotein profile (increased triglycerides, LDL, ApoB; decreased HDL), whereas insulin resistance contributes independently only to VLDL cholesterol.

Focus on reducing visceral fat rather than just total body weight. Even if you are 'lean' by BMI, high abdominal fat (measurable by CT or inferred by waist circumference) is strongly linked to bad cholesterol profiles. Lifestyle changes that reduce visceral fat (caloric restriction, exercise) improve lipid profiles, likely by reducing IAF and improving insulin sensitivity.

Longitudinal changes in moderate-to-vigorous physical activity (MVPA) during the transition from adolescence to young adulthood do not significantly predict incident obesity.

Do not rely on increasing exercise during your late teens and early twenties to prevent obesity. This study shows that changes in physical activity levels during this period do not significantly impact obesity risk. Focus instead on reducing sedentary time (screen time) as the primary strategy for weight management.

Reduced GH/IGF-1 signaling protects against age-related diseases such as diabetes and cancer in both mice and humans with GH deficiency/resistance.

Humans with genetic GH deficiency are protected from diabetes and cancer, suggesting that lower GH/IGF-1 signaling might be protective. However, this comes with trade-offs like small stature. For the general population, this does not support GH supplementation for disease prevention, as excess GH may be harmful.

Reduced GH/IGF-1 signaling extends longevity in mice through mechanisms including enhanced stress resistance, reduced inflammation, and improved insulin signaling.

The longevity benefits of low GH/IGF-1 signaling in mice are driven by better stress resistance, less inflammation, and better insulin sensitivity. This suggests that lifestyle factors improving these metrics (e.g., exercise, diet) may mimic some benefits of genetic deficiency.

Weight gain in first-year university students is not significantly different between males and females, with both gaining approximately 1.3-1.4 kg on average.

Whether you are male or female, you are equally likely to gain about 1.3-1.4 kg in your first year. Do not assume weight gain is a 'women's issue' or that men are immune. The environmental factors driving this gain affect both genders similarly.

Testosterone is the primary anabolic hormone responsible for skeletal muscle hypertrophy and strength gains, acting through genomic and non-genomic signaling pathways, whereas acute exercise-induced testosterone spikes are not the primary driver of these adaptations.

Focus on consistent resistance training and overall health rather than trying to manipulate acute hormonal spikes. Testosterone's role is foundational; if you have clinically low levels, medical intervention may be necessary, but for healthy individuals, the focus should be on the training stimulus and recovery, not chasing acute hormonal changes.

Growth Hormone (GH) assay choice significantly impacts the interpretation of exercise-induced GH responses, with bioassays detecting much higher concentrations than immunoassays due to the presence of bioactive GH aggregates.

For most exercisers, this is a research note. However, it suggests that standard blood tests for GH may not fully capture the body's anabolic response to exercise. Do not rely on single GH blood draws to judge training effectiveness.